A. Halberstadt

发表

Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer.

C. Grob, A. Danforth, G. S. Chopra, 2011, Archives of general psychiatry.

Hallucinations Under Psychedelics and in the Schizophrenia Spectrum: An Interdisciplinary and Multiscale Comparison

P. Corlett, R. Jardri, R. Carhart-Harris, 2020, Schizophrenia bulletin.

Recent advances in the neuropsychopharmacology of serotonergic hallucinogens

A. Halberstadt, 2015, Behavioural Brain Research.

Convergent neural substrates of inattention in bipolar disorder patients and dopamine transporter‐deficient mice using the 5‐choice CPT

A. Minassian, Jared W. Young, M. Geyer, 2020, Bipolar disorders.

The novel ketamine analog methoxetamine produces dissociative-like behavioral effects in rodents

S. Powell, A. Halberstadt, J. Hyun, 2016, Psychopharmacology.

Serotonergic hallucinogens as translational models relevant to schizophrenia.

M. Geyer, A. Halberstadt, 2013, The international journal of neuropsychopharmacology.

Role of the 5-HT2A receptor in the locomotor hyperactivity produced by phenylalkylamine hallucinogens in mice

M. Geyer, S. Powell, A. Halberstadt, 2013, Neuropharmacology.

Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice

M. Geyer, S. Powell, A. Halberstadt, 2011, Journal of psychopharmacology.

Behavioral effects of α,α,β,β-tetradeutero-5-MeO-DMT in rats: comparison with 5-MeO-DMT administered in combination with a monoamine oxidase inhibitor

D. E. Nichols, M. Geyer, A. Halberstadt, 2012, Psychopharmacology.

BDNF-Deficient Mice Show Reduced Psychosis-Related Behaviors Following Chronic Methamphetamine

M. van den Buuse, Elizabeth E. Manning, A. Halberstadt, 2015, The international journal of neuropsychopharmacology.

Investigation of the 2,5-dimethoxy motif in phenethylamine Serotonin 2A receptor agonists.

A. A. Jensen, J. Kristensen, A. Halberstadt, 2020, ACS chemical neuroscience.

Pharmacological and biotransformation studies of 1-acyl-substituted derivatives of d -lysergic acid diethylamide (LSD)

M. Meyer, J. McCorvy, S. Brandt, 2019, Neuropharmacology.

The role of PKC signaling in CRF-induced modulation of startle

R. Hauger, V. Risbrough, M. Tóth, 2013, Psychopharmacology.

Interactive effects of mGlu5 and 5-HT2A receptors on locomotor activity in mice

M. Geyer, S. Powell, A. Halberstadt, 2010, Psychopharmacology.

LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT2A receptor

M. Geyer, A. Halberstadt, 2009, Psychopharmacology.

Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species

J. Wallach, S. Brandt, A. Halberstadt, 2020, Neuropharmacology.

Comparison of the behavioral effects of mescaline analogs using the head twitch response in mice

S. J. Chapman, S. Brandt, A. Halberstadt, 2019, Journal of psychopharmacology.

Pharmacology and Toxicology of N-Benzylphenethylamine ("NBOMe") Hallucinogens.

A. Halberstadt, 2017, Current topics in behavioral neurosciences.

Analytical characterization of N,N-diallyltryptamine (DALT) and 16 ring-substituted derivatives.

M. Meyer, H. Maurer, S. Brandt, 2017, Drug testing and analysis.

The selective 5-HT2A receptor agonist 25CN-NBOH: structure-activity relationship, in vivo pharmacology, and in vitro and ex vivo binding characteristics of [3H]25CN-NBOH.

A. A. Jensen, H. Bräuner‐Osborne, Martin Hansen, 2020, Biochemical pharmacology.

Receptor binding profiles and behavioral pharmacology of ring-substituted N,N-diallyltryptamine analogs

P. Daley, S. Brandt, N. Cozzi, 2018, Neuropharmacology.

Effects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch response

M. Geyer, A. Halberstadt, 2014, Neuropharmacology.

Modification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors

M. Geyer, V. Risbrough, A. Halberstadt, 2008, Psychopharmacology.

Comparison of the behavioral responses induced by phenylalkylamine hallucinogens and their tetrahydrobenzodifuran (“FLY”) and benzodifuran (“DragonFLY”) analogs

S. Brandt, A. Halberstadt, M. Grill, 2019, Neuropharmacology.

N-Benzyl-5-methoxytryptamines as Potent Serotonin 5-HT2 Receptor Family Agonists and Comparison with a Series of Phenethylamine Analogues

D. E. Nichols, S. Brandt, A. Halberstadt, 2014, ACS chemical neuroscience.

Effects of the psychotomimetic benzomorphan N-allylnormetazocine (SKF 10,047) on prepulse inhibition of startle in mice

S. Powell, A. Halberstadt, J. Hyun, 2016, Pharmacology Biochemistry and Behavior.

Return of the lysergamides. Part VI: Analytical and behavioural characterization of 1-cyclopropanoyl-d-lysergic acid diethylamide (1CP-LSD).

N. Dempster, J. Wallach, T. Passie, 2020, Drug testing and analysis.

Return of the lysergamides. Part V: Analytical and behavioural characterization of 1-butanoyl-d-lysergic acid diethylamide (1B-LSD).

J. Wallach, S. Brandt, A. Halberstadt, 2019, Drug testing and analysis.

Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA)

D. E. Nichols, J. Wallach, S. Brandt, 2018, Psychopharmacology.

Return of the lysergamides. Part II: Analytical and behavioural characterization of N6 -allyl-6-norlysergic acid diethylamide (AL-LAD) and (2'S,4'S)-lysergic acid 2,4-dimethylazetidide (LSZ).

D. E. Nichols, S. J. Chapman, J. Wallach, 2017, Drug testing and analysis.

Return of the lysergamides. Part III: Analytical characterization of N6 -ethyl-6-norlysergic acid diethylamide (ETH-LAD) and 1-propionyl ETH-LAD (1P-ETH-LAD).

D. E. Nichols, J. Wallach, S. Brandt, 2017, Drug testing and analysis.

Neuropharmacology of Lysergic Acid Diethylamide (LSD) and Other Hallucinogens

M. Geyer, A. Halberstadt, 2013 .

Dopamine depletion attenuates some behavioral abnormalities in a hyperdopaminergic mouse model of bipolar disorder.

Jared W. Young, M. Geyer, X. Zhuang, 2014, Journal of affective disorders.

Investigation of the Structure-Activity Relationships of Psilocybin Analogues.

J. McCorvy, S. J. Chapman, S. Brandt, 2020, ACS pharmacology & translational science.

A novel visuospatial priming task for rats with relevance to Tourette syndrome and modulation of dopamine levels

Jared W. Young, N. Swerdlow, Richard F. Sharp, 2013, Neuroscience & Biobehavioral Reviews.

PTSD Symptom Reports of Patients Evaluated for the New Mexico Medical Cannabis Program

C. Grob, A. Halberstadt, G. Greer, 2014, Journal of psychoactive drugs.

Syntheses and analytical characterizations of novel (2-aminopropyl)benzo[b]thiophene (APBT) based stimulants.

H. Sitte, S. Brandt, A. Halberstadt, 2020, Drug testing and analysis.

International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function

B. Roth, E. Lambe, M. Camilleri, 2020, Pharmacological Reviews.

Synthesis and Biological Evaluation of Tryptamines Found in Hallucinogenic Mushrooms: Norbaeocystin, Baeocystin, Norpsilocin, and Aeruginascin.

J. McCorvy, Robert B. Kargbo, A. Halberstadt, 2020, Journal of natural products.

Pharmacological Investigations of the Dissociative ‘Legal Highs’ Diphenidine, Methoxphenidine and Analogues

G. Collingridge, Z. Bortolotto, D. Lodge, 2016, PloS one.

(2-Aminopropyl)benzo[β]thiophenes (APBTs) are novel monoamine transporter ligands that lack stimulant effects but display psychedelic-like activity in mice

H. Sitte, T. Stockner, J. McCorvy, 2021, Neuropsychopharmacology.

Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD).

J. Wallach, S. Brandt, A. Halberstadt, 2016, Drug testing and analysis.

Antomical characterization of serotonergic and nonserotonergic projections from the dorsal raphe nucleus to the vestibular nuclei.

A. Halberstadt, 2006 .

Analytical profile, in vitro metabolism and behavioral properties of the lysergamide 1P‐AL‐LAD

V. Auwärter, S. Brandt, A. Halberstadt, 2022, Drug testing and analysis.

Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens

Adam L. Halberstadt, M. Geyer, Mark A. Geyer, 2011, Neuropharmacology.

Effect of 5-HT2A and 5-HT2C receptors on temporal discrimination by mice

M. Geyer, Richard F. Sharp, A. Halberstadt, 2016, Neuropharmacology.

Dark Classics in Chemical Neuroscience: NBOMes.

J. Kristensen, A. Halberstadt, A. Jensen, 2019, ACS chemical neuroscience.

Use of the head-twitch response to investigate the structure–activity relationships of 4-thio-substituted 2,5-dimethoxyphenylalkylamines

M. Liechti, M. Hoener, D. Luethi, 2022, Psychopharmacology.

Chronic pain and psychedelics: a review and proposed mechanism of action

F. Zeidan, J. Castellanos, A. Halberstadt, 2020, Regional Anesthesia & Pain Medicine.

Premature responses in the five-choice serial reaction time task reflect rodents’ temporal strategies: evidence from no-light and pharmacological challenges

J. Enkhuizen, N. Swerdlow, M. Geyer, 2016, Psychopharmacology.

HIV Transgenic Rats Demonstrate Impaired Sensorimotor Gating But Are Insensitive to Cannabinoid (Δ9-Tetrahydrocannabinol)-Induced Deficits

A. Minassian, M. Geyer, I. Grant, 2021, The international journal of neuropsychopharmacology.

Four factors underlying mouse behavior in an open field

M. Geyer, Shoji Tanaka, A. Halberstadt, 2012, Behavioural Brain Research.

Organization of projections from the raphe nuclei to the vestibular nuclei in rats

C. Balaban, A. Halberstadt, 2003, Neuroscience.

Habituation and sensitization of acoustic startle: Opposite influences of dopamine D1 and D2-family receptors

M. Geyer, A. Halberstadt, 2009, Neurobiology of Learning and Memory.

Serotonin and schizophrenia

M. Geyer, B. Quednow, A. Halberstadt, 2020, Handbook of Behavioral Neuroscience.

Effect of Hallucinogens on Unconditioned Behavior.

M. Geyer, A. Halberstadt, 2018, Current topics in behavioral neurosciences.

Enhanced effects of amphetamine but reduced effects of the hallucinogen, 5-MeO-DMT, on locomotor activity in 5-HT1A receptor knockout mice: Implications for schizophrenia

V. Risbrough, A. Halberstadt, Sally Martin, 2011, Neuropharmacology.

Characterization of the head-twitch response induced by hallucinogens in mice

M. Geyer, A. Halberstadt, 2013, Psychopharmacology.

5-HT2A and 5-HT2C receptors exert opposing effects on locomotor activity in mice

M. Geyer, J. Gingrich, S. Powell, 2009, Neuropsychopharmacology.

Serotonin and serotonin receptors in hallucinogen action

A. Halberstadt, D. Nichols, 2020, Handbook of Behavioral Neuroscience.

Return of the lysergamides. Part IV: Analytical and pharmacological characterization of lysergic acid morpholide (LSM-775).

B. Twamley, J. McCorvy, J. Wallach, 2018, Drug testing and analysis.

Selective anterograde tracing of nonserotonergic projections from dorsal raphe nucleus to the basal forebrain and extended amygdala

C. Balaban, A. Halberstadt, 2008, Journal of Chemical Neuroanatomy.

Selective anterograde tracing of the individual serotonergic and nonserotonergic components of the dorsal raphe nucleus projection to the vestibular nuclei

C. Balaban, A. Halberstadt, 2007, Neuroscience.

2-Aminoindan and its ring-substituted derivatives interact with plasma membrane monoamine transporters and α2-adrenergic receptors

S. Brandt, A. Halberstadt, D. Walther, 2019, Psychopharmacology.

A non-hallucinogenic LSD analog with therapeutic potential for mood disorders.

Verne E. Lewis, A. Aguilar-Valles, J. McCorvy, 2023, Cell reports.

Automated detection of the head-twitch response using wavelet scalograms and a deep convolutional neural network

A. Halberstadt, 2020, Scientific Reports.

Chronic treatment with a metabotropic mGlu2/3 receptor agonist diminishes behavioral response to a phenethylamine hallucinogen

M. Geyer, S. Powell, A. Halberstadt, 2018, Psychopharmacology.

The role of PKC signaling in CRF-induced modulation of startle

R. Hauger, V. Risbrough, M. Tóth, 2013, Psychopharmacology.

Behavioral Neurobiology of Psychedelic Drugs

A. Halberstadt, E. Nichols, 2018, Current Topics in Behavioral Neurosciences.

Dimethyltryptamine: Possible Endogenous Ligand of the Sigma-1 Receptor?

A. Halberstadt, 2022 .

Hallucinogenic Drugs: A New Study Answers Old Questions about LSD

A. Halberstadt, 2017, Current Biology.

The phencyclidine-glutamate model of schizophrenia.

A. Halberstadt, 1995, Clinical neuropharmacology.

Serotonergic and nonserotonergic neurons in the dorsal raphe nucleus send collateralized projections to both the vestibular nuclei and the central amygdaloid nucleus

C. Balaban, A. Halberstadt, Carey D. Balaban, 2006, Neuroscience.

Behavioral and pharmacokinetic interactions between monoamine oxidase inhibitors and the hallucinogen 5-methoxy-N,N-dimethyltryptamine

A. Halberstadt, 2016, Pharmacology Biochemistry and Behavior.

Differences in the locomotor-activating effects of indirect serotonin agonists in habituated and non-habituated rats

M. Geyer, D. Price, A. Halberstadt, 2012, Pharmacology Biochemistry and Behavior.

Anterograde tracing of projections from the dorsal raphe nucleus to the vestibular nuclei

C. Balaban, A. Halberstadt, Carey D. Balaban, 2006, Neuroscience.

Projections from the vestibular nuclei and nucleus prepositus hypoglossi to dorsal raphe nucleus in rats

A. Halberstadt, B. Cuccurazzu, 2008, Neuroscience Letters.

Pharmacological characterizations of the 'legal high' fluorolintane and isomers.

Z. Bortolotto, D. Lodge, J. Wallach, 2019, European journal of pharmacology.

Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA)

J. Wallach, S. Brandt, A. Halberstadt, 2018, Psychopharmacology.

Analytical and behavioral characterization of N-ethyl-N-isopropyllysergamide (EIPLA), an isomer of N6 -ethylnorlysergic acid N,N-diethylamide (ETH-LAD).

V. Auwärter, S. Brandt, A. Halberstadt, 2023, Drug testing and analysis.

Analytical profile of N-ethyl-N-cyclopropyl lysergamide (ECPLA), an isomer of lysergic acid 2,4-dimethylazetidide (LSZ)

S. Brandt, A. Halberstadt, Geraldine Dowling, 2020, Drug testing and analysis.

2-Aminoindan and its ring-substituted derivatives interact with plasma membrane monoamine transporters and α2-adrenergic receptors

S. Brandt, A. Halberstadt, D. Walther, 2019, Psychopharmacology.

Acute serotonin 2A receptor activation impairs behavioral flexibility in mice

S. Powell, D. A. Amodeo, A. Halberstadt, 2020, Behavioural Brain Research.

Behavioral effects of α,α,β,β-tetradeutero-5-MeO-DMT in rats: comparison with 5-MeO-DMT administered in combination with a monoamine oxidase inhibitor

M. Geyer, A. Halberstadt, D. Nichols, 2012, Psychopharmacology.

The novel ketamine analog methoxetamine produces dissociative-like behavioral effects in rodents

S. Powell, A. Halberstadt, J. Hyun, 2016, Psychopharmacology.

Hippocampal serotonin depletion unmasks differences in the hyperlocomotor effects of phencyclidine and MK-801: quantitative versus qualitative analyses

Wendy K. Adams, M. van den Buuse, A. Halberstadt, 2013, Front. Pharmacol..

Response to Mukhdomi and Mukhdomi’s letter to the editor

F. Zeidan, J. Castellanos, A. Halberstadt, 2020, Regional Anesthesia & Pain Medicine.

Identification of 5-HT2A Receptor Signaling Pathways Responsible for Psychedelic Potential

R. Zauhar, J. McCorvy, J. Wallach, 2023, bioRxiv.

Mu-opioid receptor selective superagonists produce prolonged respiratory depression

Astrid G. Stucke, J. McCorvy, A. Stucke, 2023, iScience.

Identification of 5-HT2A receptor signaling pathways associated with psychedelic potential

J. McCorvy, A. Halberstadt, Emilie I. Anderson, 2023, Nature communications.

Modification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors

M. Geyer, V. Risbrough, A. Halberstadt, 2008, Psychopharmacology.

Pharmacology and Toxicology of N-Benzylphenethylamine ("NBOMe") Hallucinogens.

A. Halberstadt, 2017, Current topics in behavioral neurosciences.

Return of the lysergamides. Part VII: Analytical and behavioural characterization of 1-valeroyl-d-lysergic acid diethylamide (1V-LSD).

S. Brandt, A. Halberstadt, Geraldine Dowling, 2021, Drug testing and analysis.

Analytical profile of the lysergamide 1cP-AL-LAD and detection of impurities.

S. J. Chapman, V. Auwärter, S. Brandt, 2022, Drug testing and analysis.